Cellebrite Names David Barter Chief Financial Officer
David Barter, Cellebrite Chief Financial Officer
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that David Barter, a proven finance executive with extensive public company CFO experience in technology and software, has been appointed CFO, effective immediately. He succeeds Dana Gerner, who has served as Cellebrite's CFO since 2014. Gerner will remain in an active advisory role to support the transition until the Company reports its second-quarter 2025 financial results. As CFO, Barter is responsible for the Company's financial operations, including financial planning, accounting, reporting and treasury, as well as corporate development, investor relations and operations. He reports directly to CEO Thomas E. Hogan.
'On behalf of the full board, our employees, and our shareholders, I want to thank Dana Gerner for her dedication, professionalism, passion and performance. For the past eleven years, Gerner led a high-caliber finance and operations organization and played a key role in building Cellebrite into a market-leading public company, delivering consistently strong top-line growth, profitability and cash generation,' stated Hogan. 'The Company owes Dana an enormous debt of gratitude and wishes her every success as she embarks on a new and exciting chapter in her life.'
Hogan continued, 'We are thrilled to welcome Dave to Cellebrite. Dana set a high bar for her successor. We sought a leader with proven experience as a public company software CFO focused on growth and operations at scale, exceptional leadership skills, strong communication acumen and US-based with a track record of leading and operating globally.'
'It has been a great privilege to be part of Cellebrite's journey. We have accomplished a lot over the past 11 years, and the company has a bright future. I have no doubt that the team, under Dave's leadership, will continue to positively contribute to Cellebrite's success,' said Dana Gerner.
Barter brings more than three decades of public company financial leadership experience. For the last 20 years, he has been focused on scaling global software companies. Prior to joining Cellebrite, he served as CFO at New Relic where he played an instrumental role in driving the company's growth to nearly $1 billion in annual revenue, transitioning the company to a consumption-based model, improving profitability and cash flow and supporting a successful $6.5 billion sale of the business. Barter previously served as CFO at C3.ai and Model N as well as held senior finance positions at Guidewire Software, Microsoft and General Electric.
'I could not be more excited to join Cellebrite,' stated David Barter. 'The Company's unique and compelling mission and focus on public safety captured my interest and fuels my ongoing enthusiasm about joining Cellebrite. Every day, Cellebrite's technology makes a tangible difference in helping thousands of customers around the globe elevate their operational intelligence and accelerate their investigations in ways that make our world safer. I look forward to working with Cellebrite's leadership team as well as my new colleagues to effectively and efficiently expand our business around the world and deliver on our commitments to our customers, communities, employees and shareholders.'
Cellebrite will report its second-quarter 2025 financial results before market open on Thursday, August 14, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's quarterly financial results, introduce Dave Barter and provide an update on important strategic initiatives including the recently announced acquisition of Corellium. Relevant details include:
Date:
Thursday, August 14, 2025
Time:
8:30 a.m. ET
Call-In Number:
203-518-9783 / 800-267-6316
Conference ID:
CLBTQ225
Event URL:
https://investors.cellebrite.com/events/event-details/cellebrite-q2-2025-financial-results-conference-call-webcast
Live Webcast URL:
https://edge.media-server.com/mmc/p/8rnat9mu/
In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of Company's investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results.
References to Websites and Social Media PlatformsReferences to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.
About CellebriteCellebrite's (Nasdaq: CLBT) mission is to enable its global customers to protect and save lives by enhancing digital investigations and intelligence gathering to accelerate justice in communities around the world. Cellebrite's AI-powered Digital Investigation Platform enables customers to lawfully access, collect, analyze and share digital evidence in legally sanctioned investigations while preserving data privacy. Thousands of public safety organizations, intelligence agencies, and businesses rely on Cellebrite's digital forensic and investigative solutions—available via cloud, on-premises, and hybrid deployments—to close cases faster and safeguard communities. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com/investors and find us on social media @Cellebrite.
Caution Regarding Forward Looking Statements
This document includes 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as 'forecast,' 'intend,' 'seek,' 'target,' 'anticipate,' 'will,' 'appear,' 'approximate,' 'foresee,' 'might,' 'possible,' 'potential,' 'believe,' 'could,' 'predict,' 'should,' 'could,' 'continue,' 'expect,' 'estimate,' 'may,' 'plan,' 'outlook,' 'future' and 'project' and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Successful completion of the Company's quarterly financial close processes and the successful transition of the CFO role at the Company; Cellebrite's ability to keep pace with technological advances and evolving industry standards; Cellebrite's material dependence on the purchase, acceptance and use of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite's DI solutions; Cellebrite's failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of Cellebrite's markets; the inadvertent or deliberate misuse of Cellebrite's solutions; failure to manage its growth effectively; Cellebrite's ability to introduce new solutions and add-ons; its dependency on its customers renewing their subscriptions; the low volume of business Cellebrite conducts via e-commerce; risks associated with the use of artificial intelligence; the risk of requiring additional capital to support the growth of its business; risks associated with higher costs or unavailability of materials used to create its hardware product components; fluctuations in foreign currency exchange rates; lengthy sales cycle for some of Cellebrite's solutions; near term declines in new or renewed agreements; risks associated with inability to retain qualified personnel and senior management; the security of Cellebrite's operations and the integrity of its software solutions; risks associated with the negative publicity related to Cellebrite's business and use of its products; risks related to Cellebrite's intellectual property; the regulatory constraints to which Cellebrite is subject; risks associated with Cellebrite's operations in Israel, including the ongoing Israel-Hamas war and the risk of a greater regional conflict; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite's shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite's significant international operations; risks associated with Cellebrite's failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite's existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite's current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled 'Risk Factors' in Cellebrite's annual report on Form 20-F filed with the SEC on March 18, 2025, and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission ('SEC'), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Contacts:
Investors RelationsAndrew KramerVice President, Investor Relationsinvestors@cellebrite.com+1 973.206.7760
Media Jackie Labrecque Sr. Manager of Content Strategy and Operations Jackie.labrecque@cellebrite.com+1 771.241.7010
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6512336b-30e9-457b-8228-c1da62535887Sign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Defense Startups Gamble $4 Billion on Manufacturing
Silicon Valley investors are betting big on the reindustrialization of the US defense base and the startups they are backing are spending billions to bring that vision to life. Bloomberg's Lizette Chapman discusses the efforts on "Bloomberg Tech," Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Hill
5 minutes ago
- The Hill
Ethics panel: Pennsylvania Republican violated code of conduct with spouse's stock trades
The House Ethics Committee 'found substantial evidence' that Rep. Mike Kelly (R-Pa.) violated the code of conduct for the lower chamber when his wife profited off stock trades for a company the congressman was focusing on in Washington. The report — which spans 28 pages and has three packets of supporting documents — cleared Kelly of intentionally causing his wife to trade based on insider information and having a conflict of interest, determining there wasn't evidence to prove those two wrongdoings. But the panel found that Kelly, a member of the powerful Ways and Means Committee, breached the House's code of conduct 'by failing to meet his duty of candor.' The committee ordered he and his wife to divest their investments in Cleveland-Cliffs, the steel manufacturer at the center of the report. 'Representative Kelly's conduct with respect to Cleveland-Cliffs and his wife's stock purchase raised significant concerns for the Committee, even if it did not rise to the level of insider trading or clearly violate conflict of interest rules,' the committee wrote, later adding Kelly 'has not demonstrated sufficient appreciation for the harm to the institution caused by the appearance of impropriety.' The panel's investigation focuses on a series of trades of Cleveland-Cliffs stock that Kelly's wife, Victoria, made in the last five years. Cleveland-Cliffs in 2020 acquired AK Steel, which is the sole producer of grain oriented electrical steel (GOES) in the U.S. GOES is produced in Butler, Pa., a town in Kelly's district. In early 2020, Cleveland-Cliffs had said it may have to close the Butler location and lay off employees if the Trump administration did not implement Section 232 tariffs, which would protect the production of GOES in the U.S. Kelly took part in actions in Washington to address the matter. On April 28 of that year, the Commerce Department told Cleveland-Cliffs — and Kelly learned — it would begin a Section 232 investigation for some GOES-based steel products, according to the report. The next day, the panel learned, Victoria Kelly bought 5,000 shares of Cleveland-Cliffs stock for $23,075. The investigation was announced on May 4. The committee said it was unable to determine if Victoria Kelly was made aware of the development before making the trade. But, the congressman was working from home at the time after testing positive for COVID-19 and told the committee 'Mrs. Kelly would've heard any of my conversations,' adding that she 'sits around for most of the time I'm on the phone,' according to the report. The panel said it could definitely determine if she heard the conversation. The Stop Trading on Congressional Knowledge (STOCK) Act, enacted in 2012, prohibits members and staff from engaging in insider trading using information learned in official capacities. While Kelly was interviewed as part of the investigation, his wife 'refused to participate in a voluntary interview or to respond to written questions from the Committee, citing her prior cooperation with document requests as well as health concerns,' according to the report. The Congressman also said his wife did not want to speak to the committee because she felt the process was 'invasive.' 'The Committee did not receive full cooperation from Mrs. Kelly and was therefore unable to determine whether her stock purchase was improper,' the report reads. The panel did, however, find that the investment in Cleveland-Cliffs 'was an outlier' in her portfolio, noting that unlike other trades that were made at her firm's discretion, that transaction 'had to be instructed and confirmed directly by Mrs. Kelly in order for the transaction to be completed because it was not on PNC's investment platform.' The move marked her first purchase of individual stock in a year, according to the report, and was different from the mainly funds and bonds on her account. Kelly said he believed his wife made the transaction because 'she thought the stock was so low priced, it'd be foolish not to… I know that she thought she made a hell of a buy.' In August 2020, however, Kelly's office told a local news outlet inquiring about the purchase that it was made 'to show her support for the workers and management of this 100-year old bedrock of their hometown, where they both are life-long residents.' The second transaction examined by the committee was made in January 2021, shortly after Cleveland-Cliffs in December 2020 acquired a steel manufacturing corporation that caused its stock to skyrocket in value. Victoria Kelly that month sold all her shares in the company for $87,551.06, turning a $64,476.06 profit. 'None of the witnesses interviewed by OCC or the Committee, including Representative Kelly, provided an explanation for why Mrs. Kelly chose to sell her stock at that time. Representative Kelly told the Committee he did not speak with Mrs. Kelly about the sale at any point,' the report reads. Then in June 2024, Kelly disclosed that his wife purchased between $50,000 and $100,000 in shares of Cleveland-Cliffs back in March, as the congressman's office was involved in a matter involving the company and the Department of Energy. In March, the Energy Department made a decision on the matter that protected the facility in Butler. As a result of the findings, the panel recommended that Kelly and his wife 'divest all of Cleveland-Cliffs stock should he continue to take official actions relating to the company.' 'It is rare for the Committee to recommend divestment of stocks where there is a potential appearance of a conflict of interest. As Representative Kelly himself noted, however, he is an 'insider' when it comes to Cleveland-Cliffs, by virtue of his position as the representative for his district,' the report reads. In a statement responding to the Ethics report, Kelly said: 'This investigation has unnecessarily lasted for nearly five years.' 'In the years since this investigation began, the Cleveland Cliffs Butler Works plant faced an uncertain future due to the Biden administration's reckless energy policies. Throughout this process, I have fought for the 1,400 workers at the plant, I've spoken with these workers, and they appreciate the hard work we have done to fight for those jobs and for Butler. My family and I look forward to putting this distraction behind us,' he added.
Bloomberg
6 minutes ago
- Bloomberg
Bloomberg Daybreak Weekend: Fed, Tech Earnings Preview
Bloomberg Daybreak Weekend with Tom Busby take a look at some of the stories we'll be tracking in the coming week. - In the US – a look ahead to a monetary policy decision from the Fed and earnings from some of the 'Magnificent Seven' tech companies. - In the UK – a look at President Trump's trip to Scotland. - In Asia – a look at ahead to China PMI data and a conversation on Asia tech investing.
